Center for Tobacco Products, Office of Science, United States Food and Drug Administration, Silver Spring, MD, USA.
Clin Toxicol (Phila). 2022 Mar;60(3):279-285. doi: 10.1080/15563650.2021.1951284. Epub 2021 Jul 30.
Ocular injuries and unintended exposures involving electronic nicotine delivery systems (ENDS), also known as e-cigarettes, have been reported. However, trends and characteristics of ENDS-related ocular exposures at the population level are not well documented. This study was designed to describe trends and characteristics of ENDS-related ocular exposure cases reported to poison control centers (PCCs) in the U.S.
We computed descriptive statistics of ENDS-related ocular exposure cases reported to PCCs between January 1, 2010 and December 31, 2019, including number of cases per year and the distribution of characteristics of those cases. We also summarized case narrative review findings.
A total of 1,393 ENDS-related ocular exposure cases were reported to PCCs during the study period. Overall number of cases increased from two in 2010 to a peak of 389 in 2014, followed by a steady decline in 2015-2018. Of the 1,393 cases, 42.5% occurred among individuals aged 25 years and older; 20.4 and 17.7% occurred among young adults aged 18-24 years and children younger than five years, respectively. Nearly one quarter (23.8%) of the individuals experiencing ocular exposure sought or were recommended to seek medical attention. Case narrative review found that 59 of 127 (46.5%) cases were due, at least in part, to incorrect use or handling of the products.
Our study shows that more than 1,000 ENDS-related ocular exposure cases were reported to PCCs during the study period. Many of these cases involved young children; nearly half were due, at least in part, to incorrect use or handling of the products. Future efforts to prevent these exposures may focus on improving the awareness of the potential harmful effects of ENDS products and the importance of appropriate handling of ENDS products. Health care professionals may play an important role in educating patients and improving surveillance of ENDS-related ocular exposure cases.
已报道涉及电子尼古丁输送系统(ENDS),也称为电子烟的眼部损伤和意外暴露事件。然而,人群中与 ENDS 相关的眼部暴露的趋势和特征尚未得到很好的记录。本研究旨在描述美国中毒控制中心(PCC)报告的与 ENDS 相关的眼部暴露病例的趋势和特征。
我们计算了 2010 年 1 月 1 日至 2019 年 12 月 31 日期间向 PCC 报告的与 ENDS 相关的眼部暴露病例的描述性统计数据,包括每年的病例数以及这些病例特征的分布情况。我们还总结了病例叙述审查结果。
在研究期间,共有 1393 例与 ENDS 相关的眼部暴露病例向 PCC 报告。病例总数从 2010 年的 2 例增加到 2014 年的 389 例高峰,随后在 2015-2018 年稳步下降。在 1393 例病例中,42.5%发生在 25 岁及以上的人群中;20.4%和 17.7%分别发生在 18-24 岁的年轻成年人和 5 岁以下的儿童中。近四分之一(23.8%)经历眼部暴露的个体寻求或被建议寻求医疗关注。病例叙述审查发现,127 例(46.5%)病例至少部分是由于产品使用或处理不当所致。
我们的研究表明,在研究期间,向 PCC 报告了超过 1000 例与 ENDS 相关的眼部暴露病例。这些病例中有许多涉及年幼的儿童;近一半病例至少部分是由于产品使用或处理不当所致。未来预防这些暴露的努力可能侧重于提高对 ENDS 产品潜在有害影响的认识以及适当处理 ENDS 产品的重要性。医疗保健专业人员在教育患者和改善与 ENDS 相关的眼部暴露病例监测方面可能发挥重要作用。